Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Fimasartan and Rosuvastatin in Healthy Males
NCT02704702Phase 1Completed
- Sponsor
- Boryung
- Start
- Mar 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of fimasartan in hypertension (HTN) (6 arms), sponsored by Boryung. Primary endpoints: Area Under the Concentration-time Curve at Day 10, Maximum Observed Concentration at Day 10 and 1 more. Started Mar 2016; status: completed.
02
Drugs
fimasartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02704702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704702.